Johnson & Johnson

Johnson & Johnson makes medicines and medical devices for hospitals and patients. Its products help treat diseases like cancer and support surgeries and vision care. The company’s work supports doctors, hospitals, and people needing advanced healthcare solutions.

What’s in the J&J Toolbox?

• Innovative Medicine (64.2% of 2024 sales): Prescription drugs for cancer, immune disorders, and infectious diseases, used by hospitals and specialists.
• MedTech (35.8% of 2024 sales): Medical devices for surgery, orthopaedics (joint replacements), and cardiovascular care, serving hospitals and clinics.
• Vision Care: Disposable contact lenses (ACUVUE) and intraocular lenses for eye surgeries, used by eye doctors and patients.
• Advanced Surgery: Tools and products for wound closure and minimally invasive procedures, supporting surgeons and operating rooms.
• Neurovascular and Heart Recovery: Devices for stroke treatment and heart support, used in emergency and critical care settings.

Growth Moves: J&J’s Expansion Playbook

• Spun off Consumer Health as Kenvue in 2023 to focus on higher-growth segments.
• Acquired Shockwave Medical in 2024 to expand cardiovascular device offerings.
• Bought Ambrx Biopharma and Proteologix in 2024 to strengthen drug development pipeline.
• Purchased V-Wave in 2024, adding heart failure treatment technology.
• Expanded global manufacturing to 64 sites, supporting worldwide distribution and local market access.

Why J&J Stays in the Game

Johnson & Johnson operates in nearly every country, supplying hospitals and clinics worldwide. Its large research budget supports new drug and device development. The company’s broad product range and global reach help manage risks from market changes.

Five Things You Need to Know

• Revenue was $88.8 billion in 2024, up 4.3% from 2023.
• Innovative Medicine led with $57.0 billion in 2024, 64.2% of sales.
• MedTech sales reached $31.9 billion in 2024, up 4.8% year-on-year.
• R&D spending was $17.2 billion in 2024, 19.4% of sales.

Bottom Line

Johnson & Johnson has shifted to focus on prescription drugs and medical devices. Its size, research investment, and global presence support steady adaptation in healthcare markets.